What You Should Know:
- OMNY Health, a healthcare ecosystem specializing in data partnerships, today announced the launch of its GLP-1 data network.
- The GLP-1 data network aims to democratize access to healthcare data and empower researchers, clinicians, and life sciences companies to gain valuable insights into GLP-1 therapies.
Addressing Data Gaps in GLP-1 Research
Despite the growing use of GLP-1 agonists, there remains a significant lack of comprehensive data on
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
ZBiotics Raises $12M to Expand First Genetically Engineered Probiotics
What You Should Know:
- ZBiotics, the pioneers carving a new category of genetically engineered probiotics, today announced the close of its $12M Series A funding round, led by Spring Tide Capital. The oversubscribed round also includes participation by Access Capital, Seamless Capital, Goat Rodeo Capital, and Seaside Ventures.
- The company will use the funds to meet growing consumer demand, spearhead retail expansion, and drive continued research and development in a new sector,
Read More
Harvard Apparatus Regenerative Technology Secures $5M to Continue Clinical Trial
What You Should Know:
- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN), a clinical-stage biotechnology company focused on developing organ regeneration technology for severe diseases, has secured approximately $5 million from a new investor through a private placement of shares.
- The funds will be allocated to expedite the clinical development of HRGN's lead product candidate, the HRGN Esophageal Implant (BEI).
- The FDA has approved a phase one and phase two clinical
Read More
Fujitsu Partners with Paradigm for Enhanced Clinical Trials
What You Should Know:
- Fujitsu today announced a series of initiatives aimed at attracting global clinical trials to Japan and addressing the issue of drug loss.
- By partnering with pharmaceutical companies and medical institutions, Fujitsu is leveraging its expertise in technology and healthcare to create a more efficient and effective clinical trial environment.
Key Initiatives
Partnership with Paradigm: Fujitsu has formed a strategic partnership with Paradigm Health,
Read More
Jumo Health Secures Funding to Improve Clinical Trial Enrollment
What You Should Know:
- Falfurrias Management Partners (Falfurrias), a Charlotte-based private equity firm focused on growth-oriented, middle-market businesses, today announced its investment in Jumo Health, an innovative and award-winning clinical trial solutions company driving better outcomes for clinical trials globally.
- Jumo Health develops creative, patient-centric educational solutions that improve health literacy to accelerate clinical trial enrollment and increase participant
Read More
The Role of AI in Streamlining Drug Discovery and Clinical Trials: A New Era in Pharmaceutical Innovation
In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. From accelerating drug discovery to enhancing the efficiency of clinical trials, AI is revolutionizing how new medicines are brought to market. This transformation is not just limited to the research and development phases; AI is also playing a critical role in ensuring that drugs meet regulatory standards.
The AI Revolution in Drug Discovery
Drug discovery has traditionally been a
Read More
Reliant AI Emerges from Stealth with $11.3M for GenAI Biopharma Data Analysis
What You Should Know:
- Reliant AI, a provider of generative AI-powered data analytics software, today announced its official launch and a significant $11.3M in seed funding round led by Tola Capital and Inovia Capital, with participation from angel investor Mike Volpi, the investment will fuel the company's growth and expansion.
- Founded by a team of leading experts in natural language processing and reinforcement learning with backgrounds at DeepMind, Google Brain, and EY
Read More
Accenture Invests in Earli Inc. for Early Cancer Detection
What You Should Know:
- Accenture today announced a strategic investment in Earli Inc., a biotechnology company pioneering a novel approach to early cancer detection.
- Earli’s groundbreaking technology aims to transform cancer diagnosis and treatment by enabling the rapid and accurate identification of cancerous cells.
Synthetic Targeting Platform for Early Cancer Detection
Earli has developed a synthetic targeting platform that selectively reprograms cancer cells,
Read More
Medable Launches No-Code Platform for Clinical Trials
What You Should Know:
- Medable Inc., the leading technology platform for clinical trials, today announced Medable Studio, an all-in-one application for configuring, translating, validating, and launching eCOA Plus (eCOA, eConsent, Televisit, Sensors) into clinical trials.
- Studio is a no-code suite that simplifies the complex eCOA launch process, giving biopharmaceutical companies greater control and transparency for faster study go-live and earlier patient enrollment. Customers choose
Read More
Quantiphi Invests in Transcell to Advance AI-Driven Drug Discovery
What You Should Know:
- Quantiphi, an AI-first digital engineering company, announced a strategic minority investment in Transcell, a pioneering stem cell-based biotech innovator. This collaboration marks a significant step forward in the integration of AI and biotechnology for drug discovery and development.
- By combining Quantiphi’s AI expertise with Transcell’s stem cell technology, the partnership aims to accelerate the development of innovative treatments while reducing
Read More
